Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 58-63

  Huang, Haiyan ^a   Joseph, Leroy C ^a   Gurin, Michael I ^a   Thorp, Edward B ^b   Morrow, John P ^a  

^a Department of Medicine Division of Cardiology College of Physicians and Surgeons of Columbia University ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac hypertrophy; Cardiovascular disease; ERK; Neonatal rat ventricular myocytes; NF kappaB; SERCA2

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLEPHRINE; PROTEIN BINDING; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME REPRESSION; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; SARCOPLASMIC RETICULUM; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; CARDIOMEGALY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PROMOTER REGION;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; NF-KAPPA B; PHENYLEPHRINE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSCRIPTION, GENETIC;

EID: 84922748625     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.018     Document Type: Article

References (34)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
2. Andersson K.B., Birkeland J.A., Finsen A.V., Louch W.E., Sjaastad I., Wang Y., et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 2009, 47:180-187.
3. Kho C., Lee A., Jeong D., Oh J.G., Chaanine A.H., Kizana E., et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 2011, 477:601-605.
4. Kho C., Lee A., Hajjar R.J. Altered sarcoplasmic reticulum calcium cycling-targets for heart failure therapy. Nat Rev Cardiol 2012, 9:717-733.
5. Suarez J., Scott B., Dillmann W.H. Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1439-R1445.
6. Glembotski C.C. Classic studies of cultured cardiac myocyte hypertrophy: interview with a transformer. Circ Res 2013, 113:1112-1116.
7. 2+ signaling in neonatal rat cardiac myocytes. Am J Physiol Cell Physiol 2007, 292:C2269-C2275.
8. Huang Y., Wright C.D., Merkwan C.L., Baye N.L., Liang Q., Simpson P.C., et al. An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 2007, 115:763-772.
9. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000, 19:6341-6350.
10. Nediani C., Borchi E., Giordano C., Baruzzo S., Ponziani V., Sebastiani M., et al. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. J Mol Cell Cardiol 2007, 42:826-834.
11. Huang H., Amin V., Gurin M., Wan E., Thorp E., Homma S., et al. Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels. J Mol Cell Cardiol 2013, 59C:151-158.
12. Muchir A., Shan J., Bonne G., Lehnart S.E., Worman H.J. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet 2009, 18:241-247.
13. Vidal M., Wieland T., Lohse M.J., Lorenz K. beta-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gbetagamma/Erk-dependent pathway. Cardiovasc Res 2012, 96:255-264.
14. Ho P.D., Zechner D.K., He H., Dillmann W.H., Glembotski C.C., McDonough P.M. The Raf-MEK-ERK cascade represents a common pathway for alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes. J Biol Chem 1998, 273:21730-21735.
15. Liang C.P., Han S., Li G., Tabas I., Tall A.R. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment. Diabetes 2012, 61:2609-2620.
16. Guo J., Sabri A., Elouardighi H., Rybin V., Steinberg S.F. Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes. Circ Res 2006, 99:1367-1375.
17. Panama B.K., Latour-Villamil D., Farman G.P., Zhao D., Bolz S.S., Kirshenbaum L.A., et al. Nuclear factor kappaB downregulates the transient outward potassium current I(to, f) through control of KChIP2 expression. Circ Res 2011, 108:537-543.
18. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004, 10:1384-1389.
19. Zhang J., Zhang F., Ebert D., Cobb M.H., Goldsmith E.J. Activity of the MAP kinase ERK2 is controlled by a flexible surface loop. Structure 1995, 3:299-307.
20. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 1995, 92:7686-7689.
21. 2+ adenosine triphosphatase gene is increased by 3,5,3'-triiodothyronine receptor isoform-specific interactions with the myocyte-specific enhancer factor-2a. Endocrinology 1997, 138:26-32.
22. Fielitz J., Kim M.S., Shelton J.M., Qi X., Hill J.A., Richardson J.A., et al. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci U S A 2008, 105:3059-3063.
23. Babu G.J., Lalli M.J., Sussman M.A., Sadoshima J., Periasamy M. Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J Mol Cell Cardiol 2000, 32:1447-1457.
24. Bourajjaj M., Armand A.S., da Costa Martins P.A., Weijts B., van der Nagel R., Heeneman S., et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 2008, 283:22295-22303.
25. Purcell N.H., Tang G., Yu C., Mercurio F., DiDonato J.A., Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 2001, 98:6668-6673.
26. Kawano S., Kubota T., Monden Y., Kawamura N., Tsutsui H., Takeshita A., et al. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc Res 2005, 67:689-698.
27. Liu Q., Chen Y., Auger-Messier M., Molkentin J.D. Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 2012, 110:1077-1086.
28. Ho R.C., Hirshman M.F., Li Y., Cai D., Farmer J.R., Aschenbach W.G., et al. Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 2005, 289:C794-C801.
29. Oikawa K., Odero G.L., Platt E., Neuendorff M., Hatherell A., Bernstein M.J., et al. NF-kappaB p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus. BMC Neurosci 2012, 13:45.
30. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001, 107:247-254.
31. Shang L.L., Sanyal S., Pfahnl A.E., Jiao Z., Allen J., Liu H., et al. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol 2008, 294:C372-C379.
32. Wong S.C., Fukuchi M., Melnyk P., Rodger I., Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 1998, 98:100-103.
33. Hamid T., Guo S.Z., Kingery J.R., Xiang X., Dawn B., Prabhu S.D. Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 2011, 89:129-138.
34. Wahlquist C., Jeong D., Rojas-Munoz A., Kho C., Lee A., Mitsuyama S., et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014, 508:531-535.